Congratulations to Oleg Varlamov, Aaron Grossberg, Jennifer Huang, David Huang, Erik Brodt, Justin Merritt, the PEACE team, Hyunjee Kim, Amy Edmonds, Lucia Carbone, Duncan Ramsey, Pacific Northwest Evidence-based Practice Center, Eric Roeland, Kerri Winters Stone, Jessica Reid, Paula Amato, Jamie Lo, Ashley Benson, Joseph Shatzel, Motoyuki Tsuda, Kareem Woods and William Hersh.

Una infusión puntual con CRISPR puede reducir permanentemente el colesterol LDL, disminuyendo el riesgo de infarto o accidente cerebrovascular.

One-time infusion using CRISPR may permanently lower LDL cholesterol, reducing the risk of heart attack, stroke.

‘En su peor momento, nosotros damos lo mejor de nosotros’: El primer hospital infantil del estado lidera investigaciones innovadoras, tratamientos pioneros y una atención compasiva centrada en la familia.

‘In your worst moment, we’re at our best’: State’s first children’s hospital leads in groundbreaking research, pioneering treatments and compassionate, family-centered care.

Investigador de OHSU lidera un ensayo clínico internacional que estudia un posible tratamiento para la miocardiopatía hipertrófica no obstructiva.

OHSU investigator leads international clinical trial studying potential treatment for nonobstructive hypertrophic cardiomyopathy.

Informe anual clasifica especialidades de adultos de OHSU entre las primeras del país.

Annual report ranks OHSU adult specialties among the top in the country.

Congratulations to James Frank, Megan Ruhland, Matt Chan, Andrew Wang, OHSU Family Medicine Interest Group, Erick Turner, Xiaolin Nan, Nadine Mallak, Emily Van Houweling, Eric Lau, Nathan Pennock, Steven Mansoor, Lucia Carbone, Emily Voigt, Caralyn Labriola, Jacob Estes, Michael Axthelm, Brandon Wilder, Claudio Mello lab, Michael Harris, Katelyn Byrne, Greagory Baker, Erin Kenzie, Melissa Wong, Logan Jones, Taylor Anderson and Jeff Gold.